Literature DB >> 30181552

The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer.

Elena Martínez-Terroba1,2, Teresa Ezponda1,2, Cristina Bértolo1,3, Cristina Sainz1,3, Ana Remírez1, Jackeline Agorreta4,5,6,7, Irati Garmendia1,2, Carmen Behrens8, Ruben Pio1,3,9,10, Ignacio I Wistuba8,11, Luis M Montuenga12,13,14,15, María J Pajares1,2,3,9.   

Abstract

In recent years, the relevance of RNA metabolism has been increasingly recognized in a variety of diseases. Modifications in the levels of RNA-binding proteins elicit changes in the expression of cancer-related genes. Here we evaluate whether SRSF1 regulates the expression of DNA repair genes, and whether this regulation has a relevant role in lung carcinogenesis. An in silico analysis was performed to evaluate the association between the expression of SRSF1 and DNA repair genes. In vitro functional analyses were conducted in SRSF1 or DNA ligase 1 (LIG1)-downregulated non-small cell lung cancer (NSCLC) cell lines. In addition, the prognostic value of LIG1 was evaluated in NSCLC patients by immunohistochemistry. We found a significant correlation between the DNA repair gene LIG1 and SRSF1 in NSCLC cell lines. Moreover, SRSF1 binds to LIG1 mRNA and regulates its expression by increasing its mRNA stability and enhancing its translation in an mTOR-dependent manner. Furthermore, siRNA-mediated LIG1 inhibition reduced proliferation and increased apoptosis of NSCLC cells. Finally, the expression of LIG1 was an independent prognostic factor for NSCLC, as confirmed in a series of 210 patients. These results show that LIG1 is regulated by the oncoprotein SRSF1 and plays a relevant role in lung cancer cell proliferation and progression. LIG1 is associated with poor prognosis in non-small lung cancer patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30181552     DOI: 10.1038/s41374-018-0128-2

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

1.  The predictive value of RNA binding proteins in colon adenocarcinoma.

Authors:  Lipeng Luan; Feng Lu; Xiaochuan Wang; Yunliang Wang; Wei Wang; Yong Yang; Guoliang Chen; Huihui Yao; Xinyu Shi; Zihan Yuan; Guoqiang Zhou; Haitao Zhang; Songbing He
Journal:  J Gastrointest Oncol       Date:  2021-08

Review 2.  Autophagy regulation by RNA alternative splicing and implications in human diseases.

Authors:  Patricia González-Rodríguez; Daniel J Klionsky; Bertrand Joseph
Journal:  Nat Commun       Date:  2022-05-18       Impact factor: 17.694

3.  Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.

Authors:  Jun-Xian Du; Yi-Hong Luo; Si-Jia Zhang; Biao Wang; Cong Chen; Gui-Qi Zhu; Ping Zhu; Cheng-Zhe Cai; Jing-Lei Wan; Jia-Liang Cai; Shi-Ping Chen; Zhi Dai; Wei Zhu
Journal:  J Exp Clin Cancer Res       Date:  2021-05-15

4.  CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1.

Authors:  Davide Barbagallo; Angela Caponnetto; Duilia Brex; Federica Mirabella; Cristina Barbagallo; Giovanni Lauretta; Antonio Morrone; Francesco Certo; Giuseppe Broggi; Rosario Caltabiano; Giuseppe M Barbagallo; Vittoria Spina-Purrello; Marco Ragusa; Cinzia Di Pietro; Thomas B Hansen; Michele Purrello
Journal:  Cancers (Basel)       Date:  2019-02-07       Impact factor: 6.639

5.  MIR155HG Knockdown Inhibited the Progression of Cervical Cancer by Binding SRSF1.

Authors:  Ling Shen; Yuancheng Li; Guiying Hu; Yihong Huang; Xinli Song; Shun Yu; Xiaoyuan Xu
Journal:  Onco Targets Ther       Date:  2020-11-23       Impact factor: 4.147

6.  Prognostic Value and Biological Functions of RNA Binding Proteins in Stomach Adenocarcinoma.

Authors:  Junqing Li; Wenjie Zhou; Jitao Wei; Xing Xiao; Tailai An; Wenhui Wu; Yulong He
Journal:  Onco Targets Ther       Date:  2021-03-04       Impact factor: 4.147

7.  RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA.

Authors:  Ying Ye; Feng Yu; Zhao Li; Yaping Xie; Xiaohong Yu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14.

Authors:  Jia-Fu Feng; Wen-Yu Yang; Yao-Dong Wang; Gang Xie; Bei Xu; Chun-Mei Dai; Bin Zhang; Xiao-Han Li; Jun Wang; Yu-Wei Yang
Journal:  Oxid Med Cell Longev       Date:  2022-08-26       Impact factor: 7.310

9.  Integrated PPI- and WGCNA-retrieval of hub gene signatures for soft substrates inhibition of human fibroblasts proliferation and differentiation.

Authors:  Ziran Xu; Tian Zhou; Yin Wang; Leijie Zhu; Jihao Tu; Zhixiang Xu; Lisha Li; Yulin Li
Journal:  Aging (Albany NY)       Date:  2022-09-02       Impact factor: 5.955

10.  Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.

Authors:  Wei Li; Li-Na Gao; Pei-Pei Song; Chong-Ge You
Journal:  Aging (Albany NY)       Date:  2020-02-22       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.